| Prev Close: | 4.97 |
|---|---|
| Open: | 4.98 |
| Bid: | 3.82 x 100 |
| Ask: | N/A |
| 1y Target Est: | 8.25 |
| Beta: | 2.17 |
| Next Earnings Date: | 20-May-13 |
| Day's Range: | 4.77 - 4.98 |
|---|---|
| 52wk Range: | 3.68 - 7.58 |
| Volume: | 224,726 |
| Avg Vol (3m): | 262,035 |
| Market Cap: | 260.86M |
| P/E (ttm): | 30.19 |
| EPS (ttm): | 0.16 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 4 Healthcare Stock Stories For Thursday Investing Wellnessat Wall St. Cheat Sheet(Thu, May 16)
- InPlay: SciClone Pharma and Zensun enter into a licensing agreement for novel chronic heart failure drug neucardin for the China marketBriefing.com(Thu, May 16)
- SciClone Reports Anticipated Financial Results for the First Quarter 2013Marketwired(Thu, May 16)
- SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China MarketMarketwired(Thu, May 16)
- Socially Responsible Investing in Biotech and Pharmaceutical Companies: Expert Portfolio Manager Finny Kuruvilla Discusses His Construction Strategy with The Wall Street TranscriptWall Street Transcript(Thu, May 16)
- SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations anEDGAR Online(Thu, May 16)
- Income Idea: 2 Undervalued Drug Makers With Rising Gross Profit Marginsat Seeking Alpha(Fri, May 10)
- Emerging Markets an Area of Opportunity for Global Generic Players: An Expert Analyst Gives His Take on the Generic Drug SpaceWall Street Transcript(Thu, May 2)
- SciClone appoints PricewaterhouseCoopers as independent accounting firmtheflyonthewall.com(Mon, Apr 8)
- SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting FirmMarketwired(Mon, Apr 8)
- SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial StatementsEDGAR Online(Sun, Apr 7)
- SCICLONE PHARMACEUTICALS INC FinancialsEDGAR Online Financials(Fri, Apr 5)
- SCICLONE PHARMACEUTICALS INC Files SEC form 8-K/A, Changes in Registrant's Certifying Accountant, Financial StatementEDGAR Online(Fri, Apr 5)
- SciClone Pharmaceuticals Management Discusses 2012 Results - Earnings Call Transcriptat Seeking Alpha(Mon, Apr 1)
- SciClone Q4 Net Drops Steeplyat Motley Fool(Mon, Apr 1)
Press Releases
- SciClone Reports Anticipated Financial Results for the First Quarter 2013Marketwired(Thu, May 16)
- SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China MarketMarketwired(Thu, May 16)
- SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting FirmMarketwired(Mon, Apr 8)
Reports
- SCLN - SciClone Pharmaceuticals Inc - Rated a Hold - Company Analysis and ASR...Alpha Street Research(May 21)
- Market Edge Equity Research ReportMarket Edge(May 20)
- SciClone PharmaceuticalsS&P Capital IQ Quantitative Report(May 18)